UNSPSC 51401542: Oxazepam

This classification denotes a benzodiazepine with the molecular formula C15H11ClN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6GOW6DWN2A, chemically known as 1,3-dihydro-7-chloro-3-hydroxy-5-phenyl-3h-1,4-benzodiazepin-2-one but generally known as oxazepam, which bears US NIH Compound Identifier 4616. European Medicines Agency schedules Oxazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09506MIG.

UNSPSC 51401542 Oxazepam is a Commodity code. Recent state and local opportunities tagged under this code do not reflect procurement of oxazepam specifically; instead, they show solicitations for naloxone, generic multi-source pharmaceuticals, and pharmacy benefit program services. Seminole County, Florida issued an IFB in June 2026 for naloxone and drug deactivation systems, while the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) posted an RFP in January 2026 for generic multi-source pharmaceuticals and over-the-counter products across multiple state and local government facilities in Minnesota and Oregon. The Texas Health and Human Services Commission issued a Request for Information in April 2026 to explore direct-to-manufacturer prescription programs. The code shows minimal alignment with its nominal scope; the opportunities posted reflect broader pharmaceutical procurement activity rather than oxazepam-specific demand.

Issuing bodies include county health departments, state health agencies, and multistate cooperative purchasing organizations. Geographic activity spans Florida, Texas, Minnesota, and Oregon. The most representative recent opportunity is MMCAP's RFP (S1070000015802), due March 26, 2026, which targets multiple state and local government facilities across participating jurisdictions and requires vendors to supply generic pharmaceuticals through three authorized wholesalers with pricing weighted 75 percent on competitiveness and compliance with cGMP and Drug Supply Chain Security Act standards. The Seminole County IFB (IFB60459723LAS) focused on naloxone procurement with quarterly deliveries and a two-year term with one-year renewal option. Given the code's mismatch with actual solicitation content, firms pursuing state and local pharmaceutical supply contracts should monitor broader generic and brand-name pharmaceutical family codes rather than rely on this Commodity classification.